Rapid development of seizures and PRES in a COVID-19 patient.
Epilepsy Behav Rep
; 15: 100436, 2021.
Article
in En
| MEDLINE
| ID: mdl-33688630
ABSTRACT
Neurological dysfunction has been noted in up to 36% of patients hospitalized with COVID-19, and a variety of mechanisms of neurological injury are possible. Here we report the rapid development of PRES and acute seizures in a patient with COVID-19 infection and sickle cell disease. The combination of COVID and sickle cell disease may raise the risk of PRES and could contribute to the higher mortality rate of COVID in patients with sickle cell disease.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Epilepsy Behav Rep
Year:
2021
Document type:
Article
Affiliation country:
Estados Unidos